Cardiac contrast developer Biostream has named James Buchanan as CEO. Buchanan comes to the Cambridge, MA-based firm with 20 years of experience in Fortune 500 companies in the U.S. and Europe, according to Biostream.
In other appointments, Biostream has named William Eckelman, Ph.D., to chair its scientific advisory committee. Eckelman currently serves as chief of the National Institutes of Health PET department at the NIH Clinical Center in Bethesda, MD.
By AuntMinnie.com staff writersJune 25, 2002
Copyright © 2002 AuntMinnie.com